Belgium· BE-AMP-SAM156003-00
Maglid 200 mg - 200 mg
A aluminium hydroxide product containing algeldrate, registered in Belgium by Melisana. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Aluminium hydroxide is registered in 3 of 19 countries.
Countries holding a registration under ATC A02AB01 (aluminium hydroxide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Aluminium hydroxide · ATC A02AB01
3 / 19 countries
- Belgiumprice
- Japan
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Algeldrate
- Manufacturer
- Melisana
- Country
- Belgium (BE)
- ATC code
- A02AB01
- ATC class
- Aluminium hydroxide
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0280792
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for aluminium hydroxide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aluminium hydroxide · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under A02AB01
Aluminium hydroxide, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f048e805-f675-4cf0-bf6e-ea020cbb6bbe GET /v1/drugs/f048e805-f675-4cf0-bf6e-ea020cbb6bbe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Chewable tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Maglid 200 mg - 200 mg",
"name_fr": "Maglid 200 mg - 200 mg",
"name_nl": "Maglid 200 mg - 200 mg",
"amp_code": "SAM156003-00",
"strengths": [
"200.0000",
"200.0000",
"200.0000",
"200.0000"
],
"pack_count": 2,
"substances": [
"Algeldrate",
"Magnesium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Aluminium Hydroxide",
"authorisation_numbers": [
"BE156003"
]
}See everything about aluminium hydroxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.